Kovacs Z, Rauch E, DAgostino D, Ari C
Int J Mol Sci. 2024; 25(18).
PMID: 39337356
PMC: 11432942.
DOI: 10.3390/ijms25189869.
Lee N, Choi J, Ryu Y
Nucl Med Mol Imaging. 2024; 58(4):160-176.
PMID: 38932754
PMC: 11196502.
DOI: 10.1007/s13139-023-00831-4.
Hashim N, Babiker R, Mohammed R, Chaitanya N, Rahman M, Gismalla B
J Pharm Bioallied Sci. 2024; 16(Suppl 2):S1120-S1128.
PMID: 38882732
PMC: 11174192.
DOI: 10.4103/jpbs.jpbs_1120_23.
Laketa D, Lavrnja I
Mol Neurobiol. 2024; 61(10):8361-8386.
PMID: 38499905
DOI: 10.1007/s12035-024-04104-9.
Raich I, Lillo J, Ferreiro-Vera C, Sanchez de Medina V, Navarro G, Franco R
Int J Mol Sci. 2023; 24(24).
PMID: 38139329
PMC: 10744210.
DOI: 10.3390/ijms242417500.
Astrocyte-targeted siRNA delivery by adenosine-functionalized LNP in mouse TBI model.
Xiao H, Amarsaikhan O, Zhao Y, Yu X, Hu X, Han S
Mol Ther Nucleic Acids. 2023; 34:102065.
PMID: 38028196
PMC: 10661454.
DOI: 10.1016/j.omtn.2023.102065.
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy.
Fernandez M, Nigro M, Travagli A, Pasquini S, Vincenzi F, Varani K
Pharmaceutics. 2023; 15(10).
PMID: 37896201
PMC: 10610137.
DOI: 10.3390/pharmaceutics15102441.
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's Disease.
van Wamelen D, Leta V, Chaudhuri K, Jenner P
Curr Neuropharmacol. 2023; 22(10):1606-1620.
PMID: 37526188
PMC: 11284721.
DOI: 10.2174/1570159X21666230731110709.
Roles of Adenosine Receptor (subtypes A and A) in Cuprizone-Induced Hippocampal Demyelination.
Adebiyi O, Bynoe M
Mol Neurobiol. 2023; 60(10):5878-5890.
PMID: 37358743
DOI: 10.1007/s12035-023-03440-6.
The adenosine hypothesis of schizophrenia into its third decade: From neurochemical imbalance to early life etiological risks.
Singer P, Yee B
Front Cell Neurosci. 2023; 17:1120532.
PMID: 36998267
PMC: 10043328.
DOI: 10.3389/fncel.2023.1120532.
Mild inflammation impairs acute intermittent hypoxia-induced phrenic long-term facilitation by a spinal adenosine-dependent mechanism.
Marciante A, Mitchell G
J Neurophysiol. 2023; 129(4):799-806.
PMID: 36883762
PMC: 10069977.
DOI: 10.1152/jn.00035.2023.
Purinergic signaling: A gatekeeper of blood-brain barrier permeation.
Wang Y, Zhu Y, Wang J, Dong L, Liu S, Li S
Front Pharmacol. 2023; 14:1112758.
PMID: 36825149
PMC: 9941648.
DOI: 10.3389/fphar.2023.1112758.
Inflammation context in Alzheimer's disease, a relationship intricate to define.
Novoa C, Salazar P, Cisternas P, Gherardelli C, Vera-Salazar R, Zolezzi J
Biol Res. 2022; 55(1):39.
PMID: 36550479
PMC: 9784299.
DOI: 10.1186/s40659-022-00404-3.
Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?.
Hamoud A, Bach K, Kakrecha O, Henkel N, Wu X, McCullumsmith R
Int J Mol Sci. 2022; 23(19).
PMID: 36233136
PMC: 9570456.
DOI: 10.3390/ijms231911835.
Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes.
Debom G, Rubenich D, Braganhol E
Front Neurosci. 2022; 15:648476.
PMID: 35069091
PMC: 8766410.
DOI: 10.3389/fnins.2021.648476.
Lung fibrosis is induced in ADAR2 overexpressing mice via HuR-induced CTGF signaling.
Soundararajan R, Varanasi S, Patil S, Srinivas S, Hernandez-Cuervo H, Czachor A
FASEB J. 2022; 36(2):e22143.
PMID: 34985777
PMC: 10395739.
DOI: 10.1096/fj.202101511R.
Discovery of Highly Potent Adenosine A Receptor Agonists: Targeting Positron Emission Tomography Probes.
Guo M, Bakhoda A, Gao Z, Ramsey J, Li Y, OConor K
ACS Chem Neurosci. 2021; 12(18):3410-3417.
PMID: 34469110
PMC: 9353746.
DOI: 10.1021/acschemneuro.1c00397.
Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.
Matthee C, TerreBlanche G, Legoabe L, Janse van Rensburg H
Mol Divers. 2021; 26(3):1779-1821.
PMID: 34176057
DOI: 10.1007/s11030-021-10257-9.
Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells.
Franco R, Lillo A, Rivas-Santisteban R, Reyes-Resina I, Navarro G
Cells. 2021; 10(5).
PMID: 34066933
PMC: 8148598.
DOI: 10.3390/cells10051124.
Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent.
Aebersold A, Duff M, Sloan L, Song Z
Cell Physiol Biochem. 2021; 55(S5):1-14.
PMID: 33984199
PMC: 8807061.
DOI: 10.33594/000000371.